Nippon Life Global Investors Americas Inc. Lowers Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Nippon Life Global Investors Americas Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 247,280 shares of the biotechnology company’s stock after selling 25,180 shares during […]

Related Keywords

Japan ,Nippon ,Sanfordc Bernstein , ,Securities Exchange Commission ,Biomarin Pharmaceutical Inc ,Pricet Rowe Associates Inc ,Wells Fargo Company ,Nippon Life Global Investors Americas Inc ,Nasdaq ,Biomarin Pharmaceutical Company Profile ,Polar Capital Holdings Plc ,Norges Bank ,Cantor Fitzgerald ,Avoro Capital Advisors ,Nippon Life Global Investors Americas ,Biomarin Pharmaceutical ,Free Report ,Marin Pharmaceutical ,Life Global Investors Americas ,Asset Management ,Capital Advisors ,Capital Holdings Plc ,Pricet Rowe Associates ,Marin Pharmaceutical Trading Down ,Get Free Report ,Marin Pharmaceutical Inc ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,Nasdaq Bmrn ,Bmrn ,Medical ,09061g10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,